Free Trial

Bowman Consulting Group (BWMN) Competitors

Bowman Consulting Group logo
$22.23 +0.30 (+1.37%)
Closing price 04:00 PM Eastern
Extended Trading
$22.20 -0.04 (-0.16%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BWMN vs. ASTH, GB, VVX, PHR, STGW, LZ, UPBD, IBTA, APLD, and NEO

Should you be buying Bowman Consulting Group stock or one of its competitors? The main competitors of Bowman Consulting Group include Astrana Health (ASTH), Global Blue Group (GB), V2X (VVX), Phreesia (PHR), Stagwell (STGW), LegalZoom.com (LZ), Upbound Group (UPBD), Ibotta (IBTA), Applied Digital (APLD), and NeoGenomics (NEO). These companies are all part of the "business services" industry.

Bowman Consulting Group vs.

Bowman Consulting Group (NASDAQ:BWMN) and Astrana Health (NASDAQ:ASTH) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, community ranking, institutional ownership and valuation.

Astrana Health has higher revenue and earnings than Bowman Consulting Group. Astrana Health is trading at a lower price-to-earnings ratio than Bowman Consulting Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bowman Consulting Group$426.56M0.90-$6.62M$0.13171.00
Astrana Health$2.03B0.77$60.72M$0.8935.26

In the previous week, Astrana Health had 1 more articles in the media than Bowman Consulting Group. MarketBeat recorded 3 mentions for Astrana Health and 2 mentions for Bowman Consulting Group. Astrana Health's average media sentiment score of 1.40 beat Bowman Consulting Group's score of 1.24 indicating that Astrana Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bowman Consulting Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Astrana Health
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

63.2% of Bowman Consulting Group shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 20.4% of Bowman Consulting Group shares are held by insiders. Comparatively, 8.5% of Astrana Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Bowman Consulting Group presently has a consensus price target of $33.83, indicating a potential upside of 52.20%. Astrana Health has a consensus price target of $53.29, indicating a potential upside of 69.81%. Given Astrana Health's higher probable upside, analysts clearly believe Astrana Health is more favorable than Bowman Consulting Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bowman Consulting Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.40
Astrana Health
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.80

Bowman Consulting Group received 16 more outperform votes than Astrana Health when rated by MarketBeat users. However, 80.00% of users gave Astrana Health an outperform vote while only 66.67% of users gave Bowman Consulting Group an outperform vote.

CompanyUnderperformOutperform
Bowman Consulting GroupOutperform Votes
32
66.67%
Underperform Votes
16
33.33%
Astrana HealthOutperform Votes
16
80.00%
Underperform Votes
4
20.00%

Bowman Consulting Group has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, Astrana Health has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500.

Astrana Health has a net margin of 3.63% compared to Bowman Consulting Group's net margin of -2.62%. Astrana Health's return on equity of 9.37% beat Bowman Consulting Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Bowman Consulting Group-2.62% 3.76% 1.71%
Astrana Health 3.63%9.37%5.32%

Summary

Astrana Health beats Bowman Consulting Group on 12 of the 19 factors compared between the two stocks.

Remove Ads
Get Bowman Consulting Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for BWMN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BWMN vs. The Competition

MetricBowman Consulting GroupManagement consulting services IndustryBusiness SectorNASDAQ Exchange
Market Cap$383.78M$2.07B$6.94B$7.34B
Dividend YieldN/A2.95%2.69%4.31%
P/E Ratio-28.1410.1629.3017.76
Price / Sales0.9017.72169.3497.68
Price / Cash11.0262.1331.6134.64
Price / Book1.996.034.543.98
Net Income-$6.62M$106.41M$194.86M$247.44M
7 Day Performance0.41%4.91%1.56%4.43%
1 Month Performance-4.22%-4.24%-8.85%-7.73%
1 Year Performance-26.12%32.36%3.28%1.28%

Bowman Consulting Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BWMN
Bowman Consulting Group
2.6891 of 5 stars
$22.23
+1.4%
$33.83
+52.2%
-28.3%$383.78M$426.56M-28.141,000Positive News
ASTH
Astrana Health
3.6544 of 5 stars
$29.29
-2.6%
$53.29
+81.9%
-13.7%$1.47B$2.03B22.531,800Gap Down
GB
Global Blue Group
1.1276 of 5 stars
$7.24
-0.8%
$6.00
-17.1%
+50.5%$1.45B$486.34M34.481,410High Trading Volume
VVX
V2X
3.6499 of 5 stars
$45.32
-0.3%
$65.38
+44.2%
+5.9%$1.43B$4.32B161.888,100Analyst Forecast
News Coverage
PHR
Phreesia
4.2714 of 5 stars
$24.04
-1.1%
$31.33
+30.4%
+3.7%$1.41B$419.81M-16.351,700Analyst Forecast
News Coverage
STGW
Stagwell
2.4099 of 5 stars
$5.07
-4.9%
$9.08
+79.2%
-2.8%$1.35B$2.84B253.5012,200High Trading Volume
LZ
LegalZoom.com
3.2135 of 5 stars
$7.49
-4.5%
$9.19
+22.7%
-42.1%$1.32B$681.88M57.621,220Analyst Forecast
Short Interest ↑
Positive News
UPBD
Upbound Group
4.3072 of 5 stars
$21.96
-0.1%
$37.00
+68.5%
-34.3%$1.26B$4.32B9.9412,700Positive News
IBTA
Ibotta
0.4067 of 5 stars
$44.11
-0.1%
N/AN/A$1.23B$367.25M24.64N/AAnalyst Forecast
Short Interest ↑
News Coverage
APLD
Applied Digital
3.1946 of 5 stars
$5.26
+6.9%
$12.11
+130.2%
+66.5%$1.17B$211.62M-3.04121Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
Gap Down
NEO
NeoGenomics
2.5618 of 5 stars
$8.83
+0.6%
$19.60
+122.0%
-31.0%$1.13B$660.57M-14.242,100Analyst Forecast
Gap Down
High Trading Volume
Remove Ads

Related Companies and Tools


This page (NASDAQ:BWMN) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners